Anders Jack
Revolution Medicines, Inc. · Chief Financial Officer
Anders Jack is listed in filings as Chief Financial Officer at Revolution Medicines, Inc.. This profile follows SEC Form 4 activity through Jun 26, 2026, including sale activity. Recent filings connect the profile to Revolution Medicines, Inc. (RVMD) and Revolution Medicines, Inc. Warrant (RVMDW). The current snapshot covers public activity from Sep 18, 2024 to Jun 26, 2026. Reported amounts are shown as $1.6M to $761.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M9.5k shares | SellJun 24, 2026 | $168.20 | $184.44 | |
| $956k5.7k shares | SellJun 24, 2026 | $169.24 | $184.44 | |
| $762k4.6k shares | SellJun 24, 2026 | $167.35 | $184.44 | |
| $51k300 shares | SellJun 24, 2026 | $170.32 | $184.44 |